Weber Barbara — SEC Form 4 filings
SEC reporting owner CIK 1800670. 10 Form 4 filings on record with FilingPulse; latest filed 2026-06-11.
Transaction summary — filings shown
Covers all 10 filings on record, filed 2024-02-05 to 2026-06-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 7 legs across 4 filings — 63,648 shares, $796,772 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 12.
- Largest priced transaction: sale of 30,186 shares @ $12.26 ($369,999) in Tango Therapeutics, Inc., filed 2026-02-04.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Tango Therapeutics, Inc. (TNGX) | Director, Executive Chair, Director | 5 | — | 6 legs · 58,448 sh · $547,056 | 6 |
| Revolution Medicines, Inc. (RVMD) | Director | 4 | — | 1 leg · 5,200 sh · $249,716 | 5 |
| Parabilis Medicines, Inc. (PBLS) | Director | 1 | — | — | 1 |
Form 4 filings — Weber Barbara
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-06-11 | 4 | Parabilis Medicines, Inc. (PBLS) | Grant/award (A): 20,215 (derivative) @ $0 | EDGAR |
| 2026-02-04 | 4 | Tango Therapeutics, Inc. (TNGX) | Grant/award (A): 37,522 @ $0 · Sale (S): 30,186 @ $12.26 · Sale (S): 333 @ $12.90 · Grant/award (A): 222,132 (derivative) @ $0 | EDGAR |
| 2025-02-06 | 4 | Tango Therapeutics, Inc. (TNGX) | Sale (S): 9,778 @ $2.99 · Sale (S): 9,013 @ $3.16 | EDGAR |
| 2025-02-05 | 4 | Tango Therapeutics, Inc. (TNGX) | Grant/award (A): 105,875 @ $0 · Grant/award (A): 635,250 (derivative) @ $0 | EDGAR |
| 2024-10-10 | 4 | Revolution Medicines, Inc. (RVMD) | Sale (S): 5,200 @ $48.02 | EDGAR |
| 2024-08-23 | 4 | Revolution Medicines, Inc. (RVMD) | Disposition to issuer (D): 1,808 @ $44.83 | EDGAR |
| 2024-06-28 | 4/A | Revolution Medicines, Inc. (RVMD) | Grant/award (A): 4,248 @ $0 · Grant/award (A): 15,955 (derivative) @ $0 | EDGAR |
| 2024-06-24 | 4 | Revolution Medicines, Inc. (RVMD) | Grant/award (A): 4,800 @ $0 · Grant/award (A): 16,700 (derivative) @ $0 | EDGAR |
| 2024-02-08 | 4 | Tango Therapeutics, Inc. (TNGX) | Sale (S): 4,681 @ $12.56 · Sale (S): 4,457 @ $12.62 | EDGAR |
| 2024-02-05 | 4 | Tango Therapeutics, Inc. (TNGX) | Grant/award (A): 87,168 @ $0 · Grant/award (A): 523,012 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1800670 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →